Results 151 to 160 of about 11,899,379 (393)

Infectious Diseases

open access: yesJournal of the Royal College of Physicians of London, 1991
R S, Heyderman, E, Larson
openaire   +2 more sources

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich   +10 more
wiley   +1 more source

Treatment of Group A Streptococcal Pharyngitis

open access: yesCanadian Journal of Infectious Diseases, 1997
Infectious Diseases and Immunization Committee
doaj   +1 more source

Interview: Louise Dyson

open access: yesEMJ Microbiology & Infectious Diseases, 2023
Louise Dyson
doaj   +1 more source

THE ECONOMICS OF CONTROLLING INFECTIOUS DISEASES ON DAIRY FARMS [PDF]

open access: yes
Cost effective disease control on the dairy farm can enhance productivity and subsequently profitability. Previous economic studies on animal disease have focused on production losses and evaluation of disease eradication programs and provided little ...
Chi, Junwook   +3 more
core   +1 more source

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini   +13 more
wiley   +1 more source

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

open access: yesClinical Infectious Diseases, 2018
L. C. Mcdonald   +13 more
semanticscholar   +2 more sources

Geography of Infectious Diseases

open access: yes, 2010
• The geography of many infections is dynamic. • Biological characteristics of organisms, human and animal host factors, and bioclimatic factors influence where diseases occur. • Diseases vary in their potential to be moved from one area to another. Those with a fixed focal distribution often require a specific arthropod vector or intermediate host ...
openaire   +1 more source

Relapsing–Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurological impairment. While the gut microbiota's role in MS is extensively studied, the association between the oral microbiota and MS remains underexplored, particularly in North American cohorts.
Sukirth M. Ganesan   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy